Demonstration of Antibodies Against SARS-CoV-2, Neutralizing or Binding, in Seroconversion Panels After mRNA-1273, BNT-162b2, and Ad26.COV2.S Vaccine Administration by Francisco Belda BSc, MS, PhD, Oscar Mora BPharm, Monica Lopez-Martinez PhD, Nerea Torres PhD, Ana Vivanco BSc, Silvia Marfil BSc, Edwards Pradenas PhD, Marta Massanella PhD, Julià Blanco PhD, Rebecca Christie BS, Michael Crowley BBA

Get full text